FH loss predisposes to hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a cancer syndrome characterized by the presence of benign tumors of the skin and uterus and a highly aggressive form of renal cancer (4). This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.